| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The Lancet 399 (10325), 629-655, 2022 | 5590 | 2022 |
| Mycobacterium bovis BCG-Specific Th17 Cells Confer Partial Protection against Mycobacterium tuberculosis Infection in the Absence of Gamma Interferon TM Wozniak, BM Saunders, AA Ryan, WJ Britton Infection and immunity 78 (10), 4187-4194, 2010 | 164 | 2010 |
| Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses TM Wozniak, AA Ryan, WJ Britton The Journal of Immunology 177 (12), 8684-8692, 2006 | 126 | 2006 |
| Plasmid Interleukin-23 (IL-23), but Not Plasmid IL-27, Enhances the Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection TM Wozniak, AA Ryan, JA Triccas, WJ Britton Infection and immunity 74 (1), 557-565, 2006 | 95 | 2006 |
| Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection AA Ryan, JK Nambiar, TM Wozniak, B Roediger, E Shklovskaya, ... The Journal of Immunology 182 (11), 7172-7177, 2009 | 68 | 2009 |
| Using the best available data to estimate the cost of antimicrobial resistance: a systematic review TM Wozniak, L Barnsbee, XJ Lee, RE Pacella Antimicrobial Resistance & Infection Control 8, 1-12, 2019 | 65 | 2019 |
| Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs AA Ryan, TM Wozniak, E Shklovskaya, MA O’Donnell, ... The Journal of Immunology 179 (12), 8418-8424, 2007 | 54 | 2007 |
| Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model TM Wozniak, EJ Bailey, N Graves Infection Control & Hospital Epidemiology 40 (3), 320-327, 2019 | 35 | 2019 |
| Attributable length of stay, mortality risk, and costs of bacterial health care–associated infections in Australia: a retrospective case-cohort study XJ Lee, AJ Stewardson, LJ Worth, N Graves, TM Wozniak Clinical Infectious Diseases 72 (10), e506-e514, 2021 | 31 | 2021 |
| Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis NP West, TM Wozniak, J Valenzuela, CG Feng, A Sher, JMC Ribeiro, ... Vaccine 26 (31), 3853-3859, 2008 | 30 | 2008 |
| Effect of UV Radiation on the Neonatal Skin Immune System— Implications for Melanoma† HK Muller, RC Malley, HM McGee, DK Scott, T Wozniak, GM Woods Photochemistry and photobiology 84 (1), 47-54, 2008 | 27 | 2008 |
| Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia TM Wozniak, A Dyda, G Merlo, L Hall The Lancet Regional Health–Western Pacific 27, 2022 | 19 | 2022 |
| Review of the epidemiological data regarding antimicrobial resistance in Gram-negative bacteria in Australia TM Wozniak, D Paterson, K Halton Infection, Disease & Health 22 (4), 210-218, 2017 | 15 | 2017 |
| DEC‐205lo Langerinlo neonatal Langerhans' cells preferentially utilize a wortmannin‐sensitive, fluid‐phase pathway to internalize exogenous antigen BM Bellette, GM Woods, T Wozniak, KV Doherty, HK Muller Immunology 110 (4), 466-473, 2003 | 15 | 2003 |
| Geospatial epidemiology of Staphylococcus aureus in a tropical setting: an enabling digital surveillance platform TM Wozniak, W Cuningham, S Buchanan, S Coulter, RW Baird, ... Scientific Reports 10 (1), 13169, 2020 | 12 | 2020 |
| Letter to the editor in response to estimating the burden of antimicrobial resistance: a systematic literature review TM Wozniak Antimicrobial Resistance & Infection Control 7 (1), 1-2, 2018 | 11 | 2018 |
| The emergence of community-acquired Clostridium difficile in an Australian hospital TM Wozniak, G Rubin, CR MacIntyre Healthcare infection 20 (2), 72-77, 2015 | 10 | 2015 |
| Antibiotic resistance in uropathogens across northern Australia 2007–20 and impact on treatment guidelines W Cuningham, S Perera, S Coulter, GR Nimmo, T Yarwood, SYC Tong, ... JAC-antimicrobial resistance 3 (3), dlab127, 2021 | 9 | 2021 |
| How much do superbugs cost Australian hospitals? An evidence-based open-access tool TM Wozniak, N Graves, AG Barnett Infection, disease & health 23 (1), 54-56, 2018 | 9 | 2018 |
| EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach N Babu Rajendran, F Arieti, CA Mena-Benítez, L Galia, M Tebon, ... The Lancet Regional Health-Europe 26, 1-13, 2023 | 8 | 2023 |
Warwick BrittonProfessor of Medicine, University of Sydney and Centenary Institute在 centenary.org.au 的电子邮件经过验证
